# OnCo record nct03851640 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03851640/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03851640", "NCT03851640" ;
  schema:name "A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)."@en ;
  schema:description "A phase 3 trial of HC-1119 in prostate cancer, run by Hinova Pharmaceuticals Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03851640/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03851640> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2019-04-12" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:companies <https://onco.cc/companies/hinova-pharmaceuticals/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct03851640-signal-transduct-target-ther-2026/> .